Depression is common and can be disabling.
The right treatment can make a difference.
Many types of treatment exist to treat depression, and no one treatment works for everyone. People looking for help often have to try several different treatments before finding the one that works for them, which can be a frustrating process that delays recovery.
The Depression Clinical Research Program at Nova Scotia Health is recruiting participants for studies designed to answer important questions about which treatments for depression work best for whom.
Some projects at the DCRP provide treatment to participants, while others are observational. Participants found to be eligible for one of our treatment studies will receive access to best-practice care for depression at no cost.
The data we collect from study participants is used to answer key questions about depression and the effectiveness of different treatments for different individuals.
Our goal is to learn more about factors that can be used to predict treatment outcomes and help people affected by depression get the treatment they need by personalizing treatment choice.
The DCRP has several research projects currently recruiting in Nova Scotia. Click here to view projects that are currently enrolling to find out if you might be eligible. For more information, please contact the research team. There is no commitment to join once you reach out, and you are free to withdraw at any time.
The Depression Clinical Research Program (DCRP) is a research clinic operated by Nova Scotia Health.
All DCRP studies are operated under the supervision of a Nova Scotia Health staff psychiatrist and have been reviewed and approved by the Nova Scotia Health Research Ethics Board.
Select one of our studies to find out more, or sort by project type using the menu options above.
Optimized Predictive Treatment In Medications for Unipolar Major Depression
Treatment Interrupts Depression Early
Cognitive Behavioural Therapy and Anti-depressants in the Treatment of MDD and PDD
Predictors of Intravenous Ketamine Response in Treatment-Resistant Depression
Predictors of Outcomes in Mood Disorders with a Focus on Anxiety